ArticleInvestigational new drugs2025

MLN0905, a new inhibitor of Polo-like kinase 1 (PLK1), enhances the efficiency of lenalidomide in promoting the apoptosis of multiple myeloma cell lines.

Reyhane Piri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.